心臓発作診断薬市場：検査別、エンドユーザー別-2025-2030年の世界予測

心臓発作診断薬市場は、2023年に139億7,000万米ドルと評価され、2024年には149億6,000万米ドルに達すると予測され、CAGR 7.68％で成長し、2030年には234億7,000万米ドルに達すると予測されています。

心臓発作診断薬市場には、心筋梗塞を迅速かつ正確に特定するために設計されたさまざまなツールや技術が含まれます。この分野には、心電図などの診断検査、トロポニンなどの心臓バイオマーカーの血液検査、高度な画像診断技術などが含まれます。その必要性は、患者の予後を改善し死亡率を低下させるために、早期かつ正確な発見が急務であることに起因しています。これらの診断の用途は、救急外来、リスクのある人の定期検診、継続的モニタリング技術など多岐にわたる。最終用途の範囲では、病院、診療所、研究機関が主なユーザーであるが、在宅ヘルスケア環境における個人用健康モニタリング機器の動向も高まっています。

主な成長要因としては、ライフスタイルの変化による心血管疾患の有病率の増加、人口の高齢化、より高い精度でより迅速な結果を提供する診断技術の進歩などが挙げられます。新たなビジネスチャンスは、診断能力を強化するための人工知能と機械学習の統合や、非侵襲的なポイントオブケア検査ソリューションの開発にあります。企業は、研究開発への投資やテクノロジー企業との戦略的パートナーシップの形成により、こうした機会を活用し、より迅速な技術革新を図ることができます。

しかし、市場の成長は、製品承認に時間がかかる厳しい規制要件に加え、新興市場では障壁となり得る高度な診断機器の高コストといった課題に直面しています。また、診断検査における潜在的な不正確さや、リソースの少ない環境におけるヘルスケア・インフラへの依存からも限界が生じる。

遠隔地でも都市部でも使用できるポータブルでコスト効率に優れた機器の開発や、予防医療に役立つ予知診断のためのAIアルゴリズムの改良など、イノベーションを追求することができます。市場競争は激しく、大手企業は製品ラインナップを充実させるためにM&Aに注力しており、成長の機が熟したダイナミックな環境であることを示しています。全体として、心臓発作診断薬市場の潜在力を最大限に活用するには、技術的進歩への継続的投資と規制基準の遵守が不可欠です。

市場力学：急速に進化する心臓発作診断薬市場の主要市場インサイトを公開

心臓発作診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 若年および成人世代における心血管疾患の有病率の増加
  • 予防健康に対する消費者の意識の高まり
  • 座りがちなライフスタイルの増加
• 市場抑制要因
  • 心臓発作診断機器の高コスト
• 市場機会
  • 医療用画像処理技術の革新
  • 心臓発作診断薬におけるAIとMLの展開
• 市場の課題
  • 熟練した経験豊富な専門家の不足

ポーターのファイブフォース：心臓発作診断薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、心臓発作診断薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓発作診断薬市場における外部からの影響の把握

外部マクロ環境要因は、心臓発作診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓発作診断薬市場における競合情勢の把握

心臓発作診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓発作診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓発作診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓発作診断薬市場における成功への道筋を描く

心臓発作診断薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 若年層と成人世代における心血管疾患の罹患率の増加
    • 予防医療に対する消費者の意識の高まり
    • 座りがちなライフスタイルの採用の増加
  • 抑制要因
    • 心臓発作の診断機器の高コスト
  • 機会
    • 医療画像技術の革新
    • 心臓発作診断薬におけるAIとMLの導入
  • 課題
    • 熟練した経験豊富な専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓発作診断薬市場テスト別

• 血液検査
• 心エコー検査
• 心電図

第7章 心臓発作診断薬市場：エンドユーザー別

• 外来手術センター
• 診断センター
• 病院・クリニック

第8章 南北アメリカの心臓発作診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の心臓発作診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの心臓発作診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories Inc.
• ACS Diagnostics Inc.
• Asahi Kasei Corporation
• Bio-Rad Laboratories Inc.
• Bionet Co., Ltd.
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• Danaher Corporation
• F. Hoffmann La-Roche Ltd.
• FUJIFILM Holdings Corp.
• GE Healthcare Inc.
• Hill Rom Holdings Inc. by Baxter International Inc.
• Koninklijke Philips N.V.
• Nihon Kohden Corp.
• Siemens Healthineers AG

LIST OF FIGURES

• FIGURE 1. HEART ATTACK DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. HEART ATTACK DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEART ATTACK DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEART ATTACK DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 23. CANADA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 35. CHINA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 37. INDIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 72. ITALY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 80. POLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 82. QATAR HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM HEART ATTACK DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. HEART ATTACK DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. HEART ATTACK DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Heart Attack Diagnostics Market was valued at USD 13.97 billion in 2023, expected to reach USD 14.96 billion in 2024, and is projected to grow at a CAGR of 7.68%, to USD 23.47 billion by 2030.

The heart attack diagnostics market encompasses a range of tools and technologies designed to rapidly and accurately identify myocardial infarctions. The scope of this sector includes diagnostic tests such as electrocardiograms, blood tests for cardiac biomarkers like troponins, and advanced imaging techniques. Its necessity stems from the urgent need for early and precise detection to improve patient outcomes and reduce mortality rates. Applications of these diagnostics span emergency room settings, routine check-ups for at-risk individuals, and continuous monitoring technologies. In terms of end-use scope, hospitals, clinics, and research institutes are the primary users, though there's a rising trend towards personal health monitoring devices in home healthcare settings.

Key growth factors include the increasing prevalence of cardiovascular diseases due to lifestyle changes, aging populations, and advancements in diagnostic technologies that offer faster results with higher accuracy. Emerging opportunities lie in the integration of artificial intelligence and machine learning to enhance diagnostic capabilities and the development of non-invasive and point-of-care testing solutions. Companies can capitalize on these opportunities by investing in R&D and forming strategic partnerships with technology firms to innovate faster.

However, market growth faces challenges such as the high cost of advanced diagnostic equipment, which can be a barrier in emerging markets, alongside stringent regulatory requirements that elongate product approval times. Limitations also arise from potential inaccuracies in diagnostic tests and dependence on healthcare infrastructure in low-resource settings.

Innovation can be pursued in creating portable, cost-effective devices suitable for both remote and urban areas, and improving AI algorithms for predictive diagnostics, which can aid in preventive healthcare. The market is highly competitive, with major players focusing on mergers and acquisitions to enhance their product offerings, indicating a dynamic environment ripe for growth. Overall, continued investment in technological advancement and meeting regulatory standards are essential to harness the full potential of the heart attack diagnostics market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Attack Diagnostics Market

The Heart Attack Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of cardiovascular disease among younger and adult generation
  • Rising consumer awareness for preventive health
  • Higher adoption of sedentary lifestyles
• Market Restraints
  • High cost of heart attack diagnostic equipments
• Market Opportunities
  • Innovations in medical imaging technology
  • Deployment of AI and ML in heart attack diagnostics
• Market Challenges
  • Lack of skilled and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Heart Attack Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Attack Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Attack Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Attack Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Attack Diagnostics Market

A detailed market share analysis in the Heart Attack Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Attack Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Attack Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Attack Diagnostics Market

A strategic analysis of the Heart Attack Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Attack Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., ACS Diagnostics Inc., Asahi Kasei Corporation, Bio-Rad Laboratories Inc., Bionet Co., Ltd., Boston Scientific Corporation, Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann La-Roche Ltd., FUJIFILM Holdings Corp., GE Healthcare Inc., Hill Rom Holdings Inc. by Baxter International Inc., Koninklijke Philips N.V., Nihon Kohden Corp., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Heart Attack Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test, market is studied across Blood Tests, Echocardiogram, and Electrocardiogram.
• Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, and Hospital & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cardiovascular disease among younger and adult generation
    • 5.1.1.2. Rising consumer awareness for preventive health
    • 5.1.1.3. Higher adoption of sedentary lifestyles
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of heart attack diagnostic equipments
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in medical imaging technology
    • 5.1.3.2. Deployment of AI and ML in heart attack diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled and experienced professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Attack Diagnostics Market, by Test

• 6.1. Introduction
• 6.2. Blood Tests
• 6.3. Echocardiogram
• 6.4. Electrocardiogram

7. Heart Attack Diagnostics Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Diagnostics Centers
• 7.4. Hospital & Clinics

8. Americas Heart Attack Diagnostics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Heart Attack Diagnostics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Heart Attack Diagnostics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories Inc.
• 2. ACS Diagnostics Inc.
• 3. Asahi Kasei Corporation
• 4. Bio-Rad Laboratories Inc.
• 5. Bionet Co., Ltd.
• 6. Boston Scientific Corporation
• 7. Canon Medical Systems Corporation
• 8. Danaher Corporation
• 9. F. Hoffmann La-Roche Ltd.
• 10. FUJIFILM Holdings Corp.
• 11. GE Healthcare Inc.
• 12. Hill Rom Holdings Inc. by Baxter International Inc.
• 13. Koninklijke Philips N.V.
• 14. Nihon Kohden Corp.
• 15. Siemens Healthineers AG